The following is a script from "Taking on the Eiger" which aired on Nov. 29, 2015. Anderson Cooper is the correspondent. Tom Anderson, producer. The Eiger -- in the Swiss Alps -- is one of the most ...
Eiger BioPharmaceuticals, Inc. EIGR announced that it has completed rolling submission of a new drug application (“NDA”) to the FDA for its pipeline candidate, lonafarnib. The NDA seeks approval for ...
The following is a script from “Taking on the Eiger” which aired on Nov. 29, 2015, and was rebroadcast on Feb. 26, 2017. Anderson Cooper is the correspondent. Tom Anderson, producer. Michelle St. John ...
For months now, the oxygen seemed to be dwindling on Eiger’s COVID ambitions, especially after the FDA declined to grant emergency use authorization for the company’s treatment in October 2022. And ...
Add Yahoo as a preferred source to see more of our stories on Google. On Saturday morning, a major rockfall occurred on the North Face of the Eiger, covering the Swiss valley in a cloud of dust. A ...
Add Yahoo as a preferred source to see more of our stories on Google. Here are some more facts about the deadly avalanche on the Eiger yesterday. Falling ice triggered the major slide down the west ...
Clint Eastwood has been at or near the top of the movie business for more than 60 years, from the actor’s early days as The Man with No Name in the films of Sergio Leone to his sometimes controversial ...
Getting your Trinity Audio player ready... Like many serious climbers, I’ve long dreamed of climbing the Eiger Nordwand, the north face of the Alps’ most notorious peak. Fortunately, I always wake up ...
Eiger BioPharmaceuticals, Inc. EIGR is a biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is ...
Eiger BioPharmaceuticals is finally putting a pin in efforts to find a home for peginterferon lambda, a drug once tried in COVID-19 that has now failed in a study for chronic hepatitis delta. In a ...
Eiger BioPharmaceuticals, Inc. EIGR announced that it has completed rolling submission of a new drug application (“NDA”) to the FDA for its pipeline candidate, lonafarnib. The NDA seeks approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results